Literature DB >> 9131671

A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum.

J R Simon1, D J Bare, B Ghetti, J A Richter.   

Abstract

The present investigation was undertaken to test the hypothesis that a reduction in the activity of protein tyrosine kinases would result in an alteration in dopamine transport. Genistein, a broad-spectrum inhibitor of protein tyrosine kinases, inhibited dopamine uptake into mouse striatal homogenates with an IC50 of 18 microM. The inhibition by genistein was rapid, reversible and somewhat selective, in that genistein did not inhibit the uptake of choline or GABA under similar conditions. Kinetic analyses indicated that genistein was a non-competitive inhibitor. Another protein tyrosine kinase inhibitor, tyrphostin 23, also inhibited transport but was significantly less potent than genistein. Tyrphostin 25 and lavendustin A were without major effect on dopamine uptake. In addition, the inactive structural analog of genistein, genistein, had no significant effect on dopamine uptake. The inhibition of dopamine transport by 50 microM genistein was accompanied by a reduction in the level of a 110-kDa band of tyrosine phosphoprotein. It is suggested that protein tyrosine kinases play a role in the cascade of events which ultimately lead to regulation of neuronal dopamine transport.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131671     DOI: 10.1016/S0304-3940(97)13479-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

2.  Flotillins regulate membrane mobility of the dopamine transporter but are not required for its protein kinase C dependent endocytosis.

Authors:  Tatiana Sorkina; John Caltagarone; Alexander Sorkin
Journal:  Traffic       Date:  2013-03-11       Impact factor: 6.215

Review 3.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake.

Authors:  Dmitry M Mebel; Jovi C Y Wong; Yifei J Dong; Stephanie L Borgland
Journal:  Eur J Neurosci       Date:  2012-06-20       Impact factor: 3.386

5.  Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.

Authors:  Frank J S Lee; Lin Pei; Anna Moszczynska; Brian Vukusic; Paul J Fletcher; Fang Liu
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

6.  Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain.

Authors:  Y Fang; O K Ronnekleiv
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

7.  The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.

Authors:  Ana M Carneiro; Susan L Ingram; Jean-Martin Beaulieu; Ava Sweeney; Susan G Amara; Sheila M Thomas; Marc G Caron; Gonzalo E Torres
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 8.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 9.  In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.

Authors:  Rita R Fagan; Patrick J Kearney; Haley E Melikian
Journal:  Neurochem Res       Date:  2020-03-07       Impact factor: 3.996

10.  Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Authors:  Jason M Williams; W Anthony Owens; Gregory H Turner; Christine Saunders; Concetta Dipace; Randy D Blakely; Charles P France; John C Gore; Lynette C Daws; Malcolm J Avison; Aurelio Galli
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.